Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI(R) (lecanemab)
TOKYO and CAMBRIDGE, Mass., August 25, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo […]
Learn more →